AMERICAN DEPOSITARY SHARES EACH REPRESENTING 400 ORDINARY SHARES, NOMINAL VALUE £0.001 PER SHARE, PRE-FUNDED Warrants TO PURCHASE [_____________] AMERICAN DEPOSITARY SHARES and SERIES E Warrants TO PURCHASE [_____________] AMERICAN DEPOSITARY SHARES...Underwriting Agreement • December 6th, 2023 • Biodexa Pharmaceuticals PLC • Pharmaceutical preparations • New York
Contract Type FiledDecember 6th, 2023 Company Industry JurisdictionThe undersigned, Biodexa Pharmaceuticals Plc, a public limited company organized under the laws of England and Wales (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Biodexa Pharmaceuticals Plc, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. The Underlying Ordinary Shares (as defined below) and War